Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Research further shows a significant association between patients with psoriasis and an increased incidence of obstructive ...

Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...

The primary endpoint was clinical remission at week 12, with secondary endpoints of clinical response and endoscopic ...

Dermatologists say that salt can help with removing dead skin and reducing inflammation. Here's what else you should know ...

Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...

This study aims to evaluate the efficacy and safety of picankibart for the treatment of moderately to severely active ulcerative colitis (modified Mayo score of 4 to 9 with an endoscopic subscore of ...

The number of patients with the condition is projected to expand significantly in the coming years as increasing awareness and healthcare spending worldwide leads to additional diagnoses. Organon is ...

Experts explored the latest trends, approvals, and pipeline developments in cell and gene therapies, rare disease, immunology ...

Johnson & Johnson infused positive optimism after posting solid third-quarter 2024 earnings. A few analysts raised their ...